首页 | 本学科首页   官方微博 | 高级检索  
     


Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation
Authors:Atsuya Takeda MD  PhD  Naoko Sanuki MD  PhD  Yuichiro Tsurugai MD  Shogo Iwabuchi MD  PhD  Kotaro Matsunaga MD  PhD  Hirotoshi Ebinuma MD  PhD  Kento Imajo MD  PhD  Yousuke Aoki BMSc  Hidetsugu Saito MD  PhD  Etsuo Kunieda MD  PhD
Affiliation:1. Radiation Oncology Center, Ofuna Chuo Hospital, Kamakura, Kanagawa, Japan;2. Hepato‐Biliary‐Pancreatic Center, Shonan Fujisawa Tokushukai Hospital, Fujisawa, Kanagawa, Japan;3. Division of Gastroenterology and Hepatology, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan;4. Department of Gastroenterology and Hepatology, Ofuna Chuo Hospital, Kamakura, Kanagawa, Japan;5. Department of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Tokyo, Japan;6. Department of Radiation Oncology, Tokai University, Kanagawa, Japan
Abstract:
Keywords:curative treatment  hepatocellular carcinoma (HCC)  noninvasive treatment  stereotactic body radiotherapy (SBRT)
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号